BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12819312)

  • 1. The diabetes prevention program and its global implications.
    Molitch ME; Fujimoto W; Hamman RF; Knowler WC;
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S103-7. PubMed ID: 12819312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
    Knowler WC; Barrett-Connor E; Fowler SE; Hamman RF; Lachin JM; Walker EA; Nathan DM;
    N Engl J Med; 2002 Feb; 346(6):393-403. PubMed ID: 11832527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial.
    Florez H; Pan Q; Ackermann RT; Marrero DG; Barrett-Connor E; Delahanty L; Kriska A; Saudek CD; Goldberg RB; Rubin RR;
    J Gen Intern Med; 2012 Dec; 27(12):1594-601. PubMed ID: 22692637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial.
    Lindström J; Eriksson JG; Valle TT; Aunola S; Cepaitis Z; Hakumäki M; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Louheranta A; Mannelin M; Martikkala V; Moltchanov V; Rastas M; Salminen V; Sundvall J; Uusitupa M; Tuomilehto J
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S108-13. PubMed ID: 12819313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.
    ; Crandall J; Schade D; Ma Y; Fujimoto WY; Barrett-Connor E; Fowler S; Dagogo-Jack S; Andres R
    J Gerontol A Biol Sci Med Sci; 2006 Oct; 61(10):1075-81. PubMed ID: 17077202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
    Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
    Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
    Orchard TJ; Temprosa M; Goldberg R; Haffner S; Ratner R; Marcovina S; Fowler S;
    Ann Intern Med; 2005 Apr; 142(8):611-9. PubMed ID: 15838067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of body size and shape to the development of diabetes in the diabetes prevention program.
    Diabetes Prevention Program Research Group
    Obesity (Silver Spring); 2006 Nov; 14(11):2107-17. PubMed ID: 17135629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
    Ratner R; Goldberg R; Haffner S; Marcovina S; Orchard T; Fowler S; Temprosa M;
    Diabetes Care; 2005 Apr; 28(4):888-94. PubMed ID: 15793191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
    Aroda VR; Knowler WC; Crandall JP; Perreault L; Edelstein SL; Jeffries SL; Molitch ME; Pi-Sunyer X; Darwin C; Heckman-Stoddard BM; Temprosa M; Kahn SE; Nathan DM;
    Diabetologia; 2017 Sep; 60(9):1601-1611. PubMed ID: 28770322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program.
    O'Brien MJ; Whitaker RC; Yu D; Ackermann RT
    Prev Med; 2015 Aug; 77():125-30. PubMed ID: 26024851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
    Kitabchi AE; Temprosa M; Knowler WC; Kahn SE; Fowler SE; Haffner SM; Andres R; Saudek C; Edelstein SL; Arakaki R; Murphy MB; Shamoon H;
    Diabetes; 2005 Aug; 54(8):2404-14. PubMed ID: 16046308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
    Apolzan JW; Venditti EM; Edelstein SL; Knowler WC; Dabelea D; Boyko EJ; Pi-Sunyer X; Kalyani RR; Franks PW; Srikanthan P; Gadde KM;
    Ann Intern Med; 2019 May; 170(10):682-690. PubMed ID: 31009939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program.
    Sussman JB; Kent DM; Nelson JP; Hayward RA
    BMJ; 2015 Feb; 350():h454. PubMed ID: 25697494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.
    Goldberg RB; Aroda VR; Bluemke DA; Barrett-Connor E; Budoff M; Crandall JP; Dabelea D; Horton ES; Mather KJ; Orchard TJ; Schade D; Watson K; Temprosa M;
    Circulation; 2017 Jul; 136(1):52-64. PubMed ID: 28476766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.
    Ratner RE; Christophi CA; Metzger BE; Dabelea D; Bennett PH; Pi-Sunyer X; Fowler S; Kahn SE;
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4774-9. PubMed ID: 18826999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.